Recomienda este artículo a tus amigos:
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways - Resistance to Targeted Anti-Cancer Therapeutics Softcover Reprint of the Original 1st 2018 edition
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways - Resistance to Targeted Anti-Cancer Therapeutics
This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression.
242 pages, 22 Illustrations, color; XX, 242 p. 22 illus. in color.
| Medios de comunicación | Libros Paperback Book (Libro con tapa blanda y lomo encolado) |
| Publicado | 2 de febrero de 2019 |
| ISBN13 | 9783030098179 |
| Editores | Springer Nature Switzerland AG |
| Páginas | 242 |
| Dimensiones | 150 × 220 × 10 mm · 406 g |
| Lengua | Alemán |
| Editor | Elkabets, Moshe |
| Editor | Yarden, Yosef |